Abstract
Polycaprolactone (PCL) is one of the most widely used polymers in tissue engineering owing to its excellent biocompatibility, biodegradability, and processability. Nevertheless, most previous studies have primarily employed research-grade PCL, thereby limiting its clinical translation. In this study, four types of medical-grade PCL (RESOMER(®) C203, C209, C212, and C217) were systematically evaluated for their applicability in three-dimensional (3D) printing, with respect to printability, mechanical characteristics, chemical stability, and biodegradation behavior. Among these, C209 and C212 exhibited superior printability and mechanical strength. FT-IR analysis showed that the chemical structure of PCL remained unchanged after both 3D printing and E-beam sterilization, while compressive testing demonstrated no significant differences in mechanical characteristics. In vitro degradation assessment revealed a time-dependent decrease in molecular weight. For kinetic analysis, both C209 and C212 were fitted using pseudo-first-order and pseudo-second-order models, which yielded comparable coefficients of determination (R(2)), suggesting that degradation may be governed by multiple factors rather than a single kinetic pathway. Taken together, these findings indicate that medical-grade PCL, particularly C209 and C212, is highly suitable for 3D printing. Furthermore, this study provides fundamental insights that may facilitate the clinical translation of PCL-based scaffolds for tissue engineering and biomedical implantation.